Bemotuzumab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Bemotuzumab, covering 2025-05-22 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer [Phase 2]